Vistagen Therapeutics (VTGN) Asset Utilization Ratio (2012 - 2026)
Vistagen Therapeutics' (VTGN) Asset Utilization Ratio stood at 0.06 in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 604.2% from 0.01 a year earlier and up 165.5% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Asset Utilization Ratio came in at 0.02, up 308.6% from FY2025.
- Across earlier fiscal years, Asset Utilization Ratio came in at 0.00 in FY2025 (-68.2%), 0.01 in FY2024 (+210.0%), 0.00 in FY2023 (-60.9%) and 0.01 in FY2022 (-36.5%).
- The fiscal Q1 2027 figure is the highest quarterly Asset Utilization Ratio since fiscal Q1 2024.
- On a year-over-year basis, Asset Utilization Ratio has increased for five consecutive quarters, with growth averaging 105.3% over the last eight quarters.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 604.2% in fiscal Q1 2027, against a decline of 89.9% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 0.02 (Q4 2026), 0.01 (Q3 2026) and 0.01 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.06 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
API Access
Vistagen Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();